A comprehensive view of over-the-counter (otc) drugs. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Packaging Industry Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Class-action lawsuit against manufacturers and sellers of OTC medications with phenylephrine filed in British Columbia following confirmation of the drug's ineffectiveness when consumed orally; lawsuit seeks to recover money spent on purchasing drugs
Published: September 26, 2023 by Associated Press
Lawsuit targets Walmart, CVS, Target and other companies over sale of OTC medicines containing phenylephrine, deemed ineffective by a regulatory panel; the suit calls for damage payments for consumers nationwide who bought these cold and flu remedies
Published: September 18, 2023 by Monterey County Herald (CA)
FDA advisory committee unanimously votes oral phenylephrine ineffective as a decongestant, potentially impacting Nyquil, Tylenol, Advil, Robitussin, Sudafed, Benadryl and other OTC brands
Published: September 12, 2023 by The American Hospital Association (AHA)
Rite Aid announces availability of OTC Narcan nasal spray at all locations without a prescription, including Bartell Drugs in Pacific Northwest; each carton of Narcan nasal spray contains two single-dose devices priced at US$45.99
Published: September 11, 2023 by Business Wire
Walgreens announces OTC Narcan nasal spray to be available this September for US$44.99; Walgreens partners with non-profit End Overdose to educate Americans on how to administer the opioid overdose medication
Published: August 30, 2023 by Business Wire

Ask us about our Packaging Industry market view

Trending Chart

Interactive chart with headline count